Information regarding trading suspension
STOCKHOLM, 13 February 2012 - Karo Bio AB (publ) estimates to provide information on Tuesday morning related to the Stockholm Stock Exchange's decision to suspend trading in its shares. About Karo BioKaro Bio is a pharmaceutical company focused on the research and development of innovative drugs for large medical needs. The company runs a number of drug development projects within the indication areas cardiovascular and metabolic diseases, neuropsychiatry, inflammation, autoimmune diseases, cancer and women’s health. An important foundation for the company’s activities is its unique